Xeris Biopharma Holdings, Inc.
XERS
$8.48
-$0.05-0.59%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 105.36% | 91.22% | 55.04% | 31.98% | -23.57% |
| Total Receivables | 9.53% | 21.51% | 26.31% | 30.66% | 25.00% |
| Inventory | 20.28% | 40.89% | 42.55% | 49.52% | 56.55% |
| Prepaid Expenses | 134.36% | 55.83% | 28.14% | 56.95% | -18.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.05% | 53.94% | 43.33% | 37.60% | 8.95% |
|
|
|||||
| Total Current Assets | 48.05% | 53.94% | 43.33% | 37.60% | 8.95% |
| Net Property, Plant & Equipment | -3.90% | -2.91% | -4.09% | -4.10% | -3.52% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -11.60% | -11.27% | -10.96% | -10.67% | -10.39% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.73% | 0.47% | -3.46% | -2.31% | -7.86% |
| Total Assets | 23.07% | 24.27% | 18.72% | 15.29% | 0.89% |
|
|
|||||
| Total Accounts Payable | -1.32% | 80.53% | 34.32% | -12.40% | 63.19% |
| Total Accrued Expenses | 48.89% | 53.16% | 34.52% | 85.23% | 24.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,038.61% | -65.31% | -70.58% | -70.64% | 16.00% |
| Total Finance Division Other Current Liabilities | 10.08% | 16.19% | 18.28% | 18.83% | 21.58% |
| Total Other Current Liabilities | 10.08% | 16.19% | 18.28% | 18.83% | 21.58% |
| Total Current Liabilities | 99.19% | 24.74% | 9.09% | 27.67% | 26.07% |
|
|
|||||
| Total Current Liabilities | 99.19% | 24.74% | 9.09% | 27.67% | 26.07% |
| Long-Term Debt | -13.64% | 1.57% | 1.53% | 1.50% | -5.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.85% | -5.51% | -5.20% | -4.90% | -4.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 64.11% | 68.12% | 326.94% | -60.32% | -29.74% |
| Total Liabilities | 19.11% | 8.11% | 4.87% | 6.19% | 0.85% |
|
|
|||||
| Common Stock & APIC | 4.03% | 5.59% | 6.66% | 6.75% | 5.06% |
| Retained Earnings | -2.51% | 1.76% | 0.08% | -2.35% | -4.92% |
| Treasury Stock & Other | 58.33% | 4.00% | 0.00% | -56.25% | 22.58% |
| Total Common Equity | 49.58% | 137.04% | 146.22% | 96.96% | -0.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.58% | 137.04% | 146.22% | 96.96% | -0.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 49.58% | 137.04% | 146.22% | 96.96% | -0.09% |
|
|
|||||